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Abstract
Background: The complement system is becoming increasingly recognized as a key participant in many
neurodegenerative diseases of the brain. Complement-deficient animals exhibit reduced neuroinflammation.
Methods: In the present study, we administered intracerebroventricularly lipopolysaccharide (LPS) to mimic local
infection of the brain and investigated the role of key complement component C3 in brain vasculature endothelial
activation and leukocyte recruitment. The degree of neutrophil infiltration was determined by esterase staining.
Leukocyte-endothelial interactions were measured using intravital microscopy. Cerebral endothelial activation was
evaluated using real-time PCR and Western blotting.
Results: Neutrophil infiltration into the brain cortex and hippocampus was significantly reduced in C3−/− mice and
C3aR−/− mice but not in C6−/− mice. We detected markedly attenuated leukocyte-endothelial interactions in the brain
microvasculature of C3−/− mice. Accordingly, in response to LPS administration, the brain microvasculature in these
mice had decreased expression of P-selectin, E-selectin, intercellular cell adhesion molecule 1 (ICAM-1), and vascular
cell adhesion molecule 1 (VCAM-1). Depletion of C3 from the circulation also caused reduction in VCAM-1 and E-
selectin expression and leukocyte recruitment, suggesting that C3 in the circulation contributed to brain endothelial
activation. Furthermore, C3−/− mice exhibited decreased leukocyte recruitment into the brain upon tumor necrosis
factor-α (TNF-α) stimulation. C3a activated the phosphorylation of p38 mitogen-activated protein kinase (MAPK) and
nuclear factor-κB (NF-κB) and induced the upregulation of VCAM-1 and ICAM-1 expression in murine primary cerebral
endothelial cells in vitro.
Conclusions: Our study provides the first evidence that C3a plays a critical role in cerebral endothelial activation and
leukocyte recruitment during inflammation in the brain.
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Background
Although the brain is considered to be an immune-
privileged organ [1, 2], devastating effects can occur in the
brain during local inflammation, particularly in response
to cerebral bacterial infection. The recruitment of immune
cells from the circulation is critical for many life-
threatening central nervous system (CNS) inflammatory
diseases, such as bacterial meningitis [3], multiple sclerosis
[4], and stroke [5]. Neutrophils mobilized from the circu-
lation in response to signals from the CXC family of
chemokines, such as keratinocyte-derived chemokine (KC,
CXCL1), and macrophage inflammatory protein-2 (MIP-
2, CXCL2), are considered to be the first line of defense
against bacteria [6–9]. Once activated through cytokines,
such as tumor necrosis factor-α (TNF-α) and interferon-γ
(IFN-γ), endothelial cells upregulate adhesion molecule
expression, which enhances their interactions with the
leukocytes and increases their transmigration into the
brain [10, 11]. Neutrophils have been identified as the key
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players in CNS inflammation, and strategies that block
neutrophil recruitment have been demonstrated as benefi-
cial for the treatment of many types of CNS inflammation
[12–14]. In a previous study, we showed that microglia
play a dominant role in the innate immune response to in-
fectious agents in the CNS [15]. Additionally, it has been
widely accepted that inflammatory cytokines, such as
TNF-α and chemokines from glial cells, activate the endo-
thelium, thereby increasing adhesion molecule expression
and leukocyte recruitment [16–18].
The complement system consists of approximately 40
soluble and membrane-bound proteins that play a central
role in host defense against pathogens and inflammation
initiation [19, 20]. Although the liver is the primary source
of complement production, increasing evidence from re-
cent studies has shown that many types of resident cells in
the CNS produce complement components [21]. The ex-
pression of complement receptors, such as the C3a and
C5a receptors on glial cells and neurons in the CNS, has
been reported [22, 23]. Further studies in animal models
have provided evidence for the involvement of the comple-
ment system in modulating CNS inflammation [24, 25]. In
particular, systemic complement depletion reduces perihe-
matomal brain edema and TNF-α production following
experimental intracerebral hemorrhage [26]. Moreover,
C3−/− mice exhibited less brain edema and less micro-
glial activation and neutrophil infiltration around the
clot after intracerebral hemorrhage [27]. In a mouse
model of meningitis induced by Streptococcus pneumo-
nia infection, C1q and C3 deficiency led to reduced
cerebrospinal fluid (CSF) leukocyte counts in comparison
with infected wild-type (WT) mice [28]. Additionally,
mice lacking C3 and its receptors developed increased
burdens of West Nile virus in the CNS [29]. C5a receptor-
deficient mice with pneumococcal meningitis also showed
lower CSF leukocyte counts and alleviated brain damage
compared with WT mice. Moreover, treatment with C5-
specific monoclonal antibodies prevented animal death in
WT mice with pneumococcal meningitis [30]. These stud-
ies suggest that the complement system plays a significant
role in the CNS inflammatory response. However, the
mechanisms underlying the contribution of complement
components to immune cell recruitment into the brain
parenchyma through the blood-brain barrier (BBB) re-
main unclear.
In this study, we systemically examined the detailed
mechanisms underlying the contribution of complement
components to leukocyte recruitment in response to
cerebral lipopolysaccharide (LPS) administration. We first
detected significantly reduced infiltrating neutrophils in
the brain of C3-deficient (C3−/−) and C3a receptor-defi-
cient (C3aR−/−) but not C6-deficient (C6−/−) mice. C3
deficiency also significantly reduced endothelial activa-
tion and leukocyte-endothelial interactions in brain
postcapillary venules. Permeability changes in the BBB
were comparable between WT and C3−/− mice. Adhesion
molecules, such as E-selectin and vascular cell adhesion
molecule 1 (VCAM-1), showed reduced expression levels
in the brains of C3−/− mice in response to LPS administra-
tion, suggesting that C3 contributes to the activation of
brain endothelium. Furthermore, TNF-α was not able to
induce leukocyte recruitment in C3−/− mice. C3a directly
stimulated cerebral endothelial activation in vitro. Taken
together, these results demonstrate that C3a plays a critical
role in endothelial activation and subsequent leukocyte re-




Adult male wild-type (WT) C57BL/6J and BALB/c mice 7
to 8 weeks old weighing 20 to 25 g were obtained from the
Model Animal Research Center, Nanjing University. C3-
deficient (C3−/−) mice (C57BL/6J mice background) and
C3a receptor-deficient (C3aR−/−) mice (BALB/c mice back-
ground) were purchased from the Jackson Laboratory (Bar
Harbor, ME, USA). The C5aR−/− mice (C57BL/6J back-
ground) were obtained from Dr. Hu Weiguo (Shanghai
Cancer Center and Institute of Biomedical Science,
Shanghai Medical College, Fudan University, China).
The C6-deficient (C6−/−) mice (C57BL/6J mice back-
ground) were a gift from Dr. Tod Merkel (Center for
Biologics Evaluation and Research, Food and Drug Ad-
ministration, USA). The animals were housed under a
12-h light/dark cycle under specific pathogen-free con-
ditions with free access to food and water. All animal
protocols were reviewed and approved by the Institu-
tional Animal Care and Use Committee of Nanjing
Medical University. All animal experiments were car-
ried out in a blinded and randomized fashion.
Intracerebroventricular LPS injection
The mice were anesthetized using an intraperitoneal (i.p.)
injection of 200 mg/kg of ketamine and 10 mg/kg of xyla-
zine. Subsequently, the mice were placed onto a rodent
stereotaxic frame (David Kopf Instruments, Tujunga, CA,
USA). The scalp was shaved, and a burr hole was drilled
1 mm caudal to the bregma and 2.0 mm lateral to the mid-
line [15, 31]. A total of 2 μL of 2 μg of LPS (Escherichia
coli serotype 0111:B4 strain; InvivoGen) or 0.2 μg of TNF-
α (R&D systems, Minneapolis, MN, USA) was adminis-
tered by intracerebroventricular (i.c.v.) injection using a
10-μl Hamilton microsyringe over a 3-min period. Control
animals received an isovolumetric i.c.v. injection of saline.
Body temperature was monitored using a rectal probe, and
the mice were maintained under deep anesthesia at 36 ±
1 °C using a thermostatic heating system (Harvard Appar-
atus, MA, USA) throughout the experiment.
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Immunohistochemical procedure
Mice under deep anesthesia and received i.c.v. LPS or
saline injection were perfused through the heart with
ice-cold 4 % formalin. The cerebral tissues were then re-
moved and fixed in 4 % formalin for 48 h. Thick coronal
sections were obtained at −1.0 to −3.0 mm from the
bregma. Formalin-fixed tissues were embedded in paraf-
fin and subsequently sectioned at a 4-μm thickness using
a cryostat. Infiltrating neutrophils were detected using a
Naphthol AS-D Chloroacetate-Specific Esterase kit
(Sigma-Aldrich, St. Louis, MO, USA).
Intravital microscopy
The animals were anesthetized and monitored as de-
scribed previously [15]. A craniotomy was performed
using a high-speed drill in the right parietal bone. Strip-
ping the dura from the site exposed the brain pial vessels.
Subsequently, the animals were intravenously (i.v.) admin-
istered rhodamine 6G (Sigma-Aldrich) (0.5 mg/kg, body
weight) to label leukocytes. Leukocyte-endothelial interac-
tions were recorded using an sCMOS camera (ORCA-
Flash 4.0, HAMAMATSU) mounted onto a Nikon FN1
microscope. Three different postcapillary venules with di-
ameters between 30 and 70 μm were chosen for observa-
tion. All experiments were recorded for subsequent
playback analysis. Rolling leukocytes were defined as cells
moving at a velocity less than that of erythrocytes. Cells
remaining stationary for at least 30 s were considered
adherent.
Blood-brain barrier permeability determination
The levels of albumin, a plasma protein that is normally
excluded from the brain by the intact BBB, were used as
an indicator for its integrity. The mice were anesthetized
and perfused with 20 ml of ice-cold phosphate-buffered
saline (PBS) to remove contaminated albumin from the
circulation. Then, the concentration of albumin in brain
homogenates was measured by Western blotting as pre-
viously described [32].
Complement depletion
Four hours prior to i.c.v. LPS injection, hypocomple-
mentemia was induced through the i.p. injection of
cobra venom factor (CVF) (Biogen Sci & Tech Co.,
Kunming, China) in PBS into C57BL/6J mice at a dose
of 10 μg/mouse (15 U/mouse). This treatment depletes
complement within 4 h of the injection, reducing the
levels of C3 in the circulation to less than 3 % of the
normal range, which persists for at least 48 h post-
injection [33, 34].
RNA isolation and real-time quantitative PCR
Total RNA was extracted from brain tissue using Trizol
reagent (Invitrogen, Carlsbad, CA, USA) and was then
reversely transcribed using Superscript II (Invitrogen,
Carlsbad, CA, USA). Real-time PCR was performed using a
SYBR green PCR reagent according to the manufacturer’s
instructions (Applied Biosystems, Yerevan, Armenia). The
following DNA sequences were used for the primer pairs:
P-selectin forward primer, 5'-TCCAGGAAGCTCTGACG
TACTTG-3'; P-selectin reverse primer, 5'-GCAGCGTT
AGTGAAGACTCCGTAT-3'; E-selectin forward pri-
mer, 5‘-TGAACTGAAGGGATCAAGAAGACT-3'; and
E-selectin reverse primer, 5'-GCCGAGGGACATCATC
ACAT-3'; VCAM-1 forward primer, 5‘-TGACAAGTC
CCCATCGTTGA-3'; and VCAM-1 reverse primer,
5'-ACCTCGCGACGGCATAATT-3'; intercellular cell
adhesion molecule (ICAM-1) forward primer, 5‘-CC
TGTTTCCTGCCTCTGAAG-3'; and ICAM-1 reverse
primer, 5'-GTCTGCTGAGACCCCTCTTG-3'. Mouse
β2-microglobulin (β2-MG) was used as an internal control
with the following primer sequences: β2-MG forward
primer, 5'-CCTGCAGAGTTAAGCATGACAGT-3'; and
β2-MG reverse primer, 5'-TCATGATGCTTGATCACAT
GTCT-3'. Quantitative PCR was performed with an ABI
Prism 7300 spectrofluorometric thermal cycler (Applied
Biosystems) using SYBR Green I as a double-stranded
DNA-binding dye. The amplification conditions consisted
of 95 °C (2 min), followed by 32 cycles of 95 °C (20 s),
57.2 °C (30 s), and 72 °C (30 s). Quantitative PCR assays
were conducted in triplicate and were then quantitated
using the 2−ΔΔCt method. The data are expressed as n-fold
differences relative to the calibrator.
Enzyme-linked immunosorbent assay
The mice were anesthetized after LPS injection and sub-
sequently perfused through the heart with cold PBS to
remove blood proteins from the circulation. The brains
were rapidly removed and homogenized in 1 ml of ster-
ile PBS, followed by centrifugation at 12,000 rpm for
5 min at 4 °C. The supernatants were assayed for deter-
mining TNF-α and IL-1β concentrations using commer-
cial enzyme-linked immunosorbent assay (ELISA) kits
(TNF-α, BD, San Diego, CA, USA; IL-1β, eBioscience,
San Diego, CA, USA) according to the manufacturers’
instructions. To measure the levels of C3a in brain and
plasma of mice, plates were coated with 100 μl of rat
anti-mouse capture antibody specifically against C3a
(BD Biosciences, San Jose, CA, USA) at 1:250 dilutions
in PBS overnight at 4 °C. FUT-175 (BD Biosciences)
which was dissolved with 1 ml ddH2O, a synthetic in-
hibitor for the classical and alternate pathways of com-
plement activation, was added into the EDTA blood and
brain samples according to the manufacturer’s instruc-
tions. In details, 10 μl of FUT-175 was added into 1 ml
of freshly drawn EDTA blood or brain supernatant on
ice. After centrifugation, the plasma and brain proteins
in these samples were collected for the ELISA assay.
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Brain, plasma samples, or C3a standard solution
were diluted and added to the plates coated with
capture antibody and incubated at room temperature
for 2 h, and purified mouse C3a protein (BD Bio-
science) was set as standard. Brain and plasma samples
from C3−/− mice were set as negative control. After wash-
ing four times, 100 μl of biotin-conjugated rat anti-mouse
C3a (BD Biosciences) at 1:500 dilution in PBS with 10 %
FBS was added to each well and incubated at room
temperature for 1 h. The wells were washed again and
then incubated with a 1:250 dilution of streptavidin/
horseradish peroxidase (HRP) (BD Biosciences) for 1 h
at room temperature. The wells were washed, and
100 μl of substrate solution (BD Biosciences) was added
to each well. The color was developed for 10–20 min
with the reaction stopped by the addition of 2N H2SO4.
Absorbance was read at 450 nm with correction for ab-
sorbance at 550 nm.
Western blotting
The complement factor C3 and albumin were analyzed
in the brain homogenates and plasma samples obtained
from experimental mice. To obtain the brain homoge-
nates, the mice were anesthetized at 4, 12, and 24 h
after i.c.v. LPS injection and subsequently perfused
with ice-cold PBS to clear blood-borne proteins. Each
brain was removed and homogenized in PBS on ice,
followed by centrifugation at 12,000 rpm for 5 min. For
the analysis of plasma complement content, blood
(100–400 μl) was obtained by intracardiac puncture of
anesthetized animals immediately prior to the perfu-
sion. 10 μl of FUT-175 (Futhan) was immediately
added into each milliliter of the freshly drawn EDTA
blood on ice. After centrifugation at 2500 rpm for
10 min, these plasma samples were boiled in loading
buffer for another 10 min. Subsequently, the samples
were diluted and separated on a 10 % acrylamide-
Fig. 1 Effects of C3 and C6 deficiency on neutrophil recruitment into the brain parenchyma after i.c.v. LPS injection. a WT C57BL/6J mice (n = 8),
C3−/− mice (n = 8), and C6−/− mice (n = 4) received i.c.v. injections of saline or LPS. After 24 h, esterase staining was performed to quantitate the
neutrophils infiltrating into the cortex and hippocampus. LPS i.c.v. injection induced substantial infiltrations of neutrophils into the cortex and
hippocampus of WT C57BL/6J mice. C3 deficiency significantly reduced neutrophil infiltration into the cortex and hippocampus. C6 deficiency did
not reduce neutrophil recruitment. The quantitative data of infiltrated neutrophils in the cortex (b) and hippocampus (c) are shown as
the means ± SEM. Magnification, ×400. *P < 0.05, **P < 0.01
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sodium dodecyl sulfate (SDS) gel, followed by transferring
onto membranes and blotting overnight at 4 °C with the
following antibodies: anti-C3 (Abcam, Cambridge, USA),
anti-albumin (Abcam), anti-E-selectin (Abcam), anti-
VCAM-1 (Abcam), anti-ICAM-1 (Abcam), anti-GAPDH
(Abcam), anti-NF-kB p65 (Cell Signaling Technology,
Beverly, CA, USA), anti-phospho-NF-κB p65 antibody
(Cell Signaling Technology), and anti-β-actin (Cell Signal-
ing Technology). The membrane was washed (0.05 %
Tween-20 in PBS), incubated with peroxidase-labeled goat
anti-rabbit IgG or anti-goat IgG, and washed again. Anti-
body binding was visualized using enhanced chemilumin-
escence reagents (PerkinElmer, Waltham, MA, USA).
Densitometric images were quantified using ImageJ soft-
ware (National Institutes of Health, Bethesda, MD, USA).
Relative expression levels of proteins were normalized to
β-actin.
Isolation and culture of murine cerebral endothelial cells
The mice were sacrificed, and their brains were col-
lected. The cerebral cortices, devoid of cerebella, white
matter, and leptomeninges, were minced into small
pieces. The pellet was digested in 15 ml of 0.1 % collage-
nase B (Roche, Indianapolis, IN, USA) supplemented
with 30 U/ml of DNase I (Sigma-Aldrich) for 1.5–2 h at
37 °C with occasional agitation. The microvessels were
isolated through gradient centrifugation on 15 % dextran
(Sigma-Aldrich) and subsequently digested in 0.1 %
collagenase/dispase (Roche) supplemented with 20 U/ml
of DNase I for 1.5–2 h at 37 °C with occasional agita-
tion. The microvessel pellets were resuspended in
medium supplemented with 3 ng/ml of bovine fibroblast
growth factor (bFGF, Peprotech, Rocky Hill, NJ, USA),
30 % fetal bovine serum (FBS), 10 U/ml of heparin,
100 U/ml of penicillin, and 100 mg/ml of streptomycin.
The microvessel suspension was plated onto 6-well
plates coated with rat-tail collagen I (Sigma-Aldrich) and
incubated at 37 °C with 5 % CO2. The medium was
changed every 2 days. The endothelial cells began mi-
grating from the vessels within 2–3 days and grew to
confluence within 7–10 days.
Statistical analysis
Statistical analysis was performed using SPSS software
(17.0 for Windows, IBM Inc., Chicago, IL, USA). The
values are expressed as the means ± standard errors of
the mean (SEM). Differences between the two groups
were analyzed using Student’s t test, and P < 0.05 was
considered significant.
Results
C3 deficiency decreases LPS-induced neutrophil recruitment
into the brain
To examine the roles of complement components in
neutrophil recruitment into the CNS, WT C57BL/6J
mice, C3−/− mice, and C6−/− mice were subjected to i.c.v.
Fig. 2 Leukocyte-endothelial interactions in WT and C3−/− and C6−/− mice after i.c.v. LPS injection. WT C57BL/6J mice and C3−/− and C6−/− mice
received i.c.v. injections of LPS or saline, and leukocyte-endothelial interactions were examined through intravital microscopy. a WT C57BL/6J mice
with saline injection showed no evident recruitment into CNS vessels. After i.c.v. injection of LPS, WT C57BL/6J mice with LPS injection showed
significant recruitment into CNS vessels (b), and C3−/− mice exhibited reduced recruitment into the CNS (c). d C6−/− mice exhibited leukocyte-
endothelial interactions comparable with those observed in WT mice. The numbers of rolling (e) and adhesive cells (f) are shown as the
means ± SEM; n = 6 for all groups, **P < 0.01, ***P < 0.001
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LPS injection. Brain sections from these mice were stained
with esterase to evaluate neutrophil recruitment. In re-
sponse to LPS, neutrophils initiated extravasation into the
brain at 12 h post-injection, and infiltration peaked at
24 h in the cortex and hippocampus and subsequently de-
creased. Compared with WT mice, the number of neutro-
phils infiltrated into the brain cortex and hippocampus
was significantly reduced in C3−/− but not C6−/− mice
(Fig. 1a–c).
Using intravital microscopy, we further examined the
roles of complement components in leukocyte-endothelial
interactions in postcapillary venules in the CNS. The i.c.v.
administration of saline did not induce leukocyte rolling
and adhesion in brain postcapillary venules of WT mice
(Fig. 2a). The i.c.v. administration of LPS induced signifi-
cant leukocyte rolling and adhesion in brain postcapillary
venules of WT mice (Fig. 2b, Additional file 1). Consistent
with the immunohistochemical results, leukocyte recruit-
ment in brain vessels was significantly reduced in the
brain venules of C3−/− (Fig. 2c, Additional file 2) but not
C6−/− mice (Fig. 2d, Additional file 3) at 4 h post-
injection. Rolling (Fig. 2e) and adherent leukocytes (Fig. 2f)
were quantified in WT, C3−/−, and C6−/− mice. Taken to-
gether, these results suggest that neutrophil recruitment
Fig. 3 Effect of C3 deficiency on the expression of endothelial adhesion molecules and the BBB permeability changes in the brain. WT C57BL/6J
mice and C3−/− mice received i.c.v. injections of LPS; 4 h later, mRNA expression in brain tissue was quantified using real-time PCR. a C3 deficiency
resulted in the downregulation of brain P-selectin, E-selectin, ICAM-1, and VCAM-1 mRNA expression (n≥ 8). b VCAM-1 and E-selectin protein levels
were measured through Western blotting analysis; the ratio of VCAM-1 and E-selectin to β-actin was determined through densitometry (n = 5). c To
assess BBB permeability, mouse brain homogenates were examined for albumin infiltration using Western blotting analysis (n = 6). Albumin levels in
the brain proteins were measured at 4, 12, and 24 h after LPS i.c.v. The results are shown as the means ± SEM; *P < 0.05
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Fig. 4 (See legend on next page.)
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induced through i.c.v. LPS administration requires C3 but
not C6.
C3 deficiency decreases LPS-induced brain endothelial
adhesion molecule expression but not permeability
changes
Adhesion molecules primarily mediate leukocyte-
endothelial interactions and are markers of endothe-
lial activation in acute inflammation [35, 36]. To determine
whether C3 deficiency influenced endothelial activation, we
examined the mRNA expression levels of different adhesion
molecules upon LPS injection in C3−/− mice. C3 deficiency
resulted in significant reduced P-selectin, E-selectin,
ICAM-1, and VCAM-1 transcription in the brain at 4 h
after LPS injection (Fig. 3a). Moreover, Western blotting
analysis also revealed the reduced expression of VCAM-1
and E-selectin in the brain of C3−/− mice (Fig. 3b).
BBB permeability profoundly affects leukocyte recruit-
ment in the brain. To examine whether C3 deficiency
led to altered BBB permeability, we measured the brain
concentrations of albumin leaked from the circulation
into the brain tissues in LPS-treated WT and C3−/−
mice. The i.c.v. injection of LPS induced time-dependent
increases in BBB permeability. However, there was no
significant difference in the permeability between WT
and C3−/− mice (Fig. 3c). Taken together, these data sug-
gest that reduced endothelial adhesion molecule expres-
sion caused by lower grade of endothelial activation, but
not the altered brain BBB permeability, led to the re-
duced neutrophil recruitment in C3−/− mice. Clearly, C3
deficiency affected the activation of the brain endothe-
lium upon LPS challenge.
C3 depletion from circulation affected leukocyte
recruitment in the brain
Virtually all complement components can be locally pro-
duced in the CNS in response to injury or inflammation
[21]. To determine the source of C3, which plays a
major role in endothelial activation, we assessed the C3
levels in the CNS and blood circulation. C3 was virtually
undetectable in the brain parenchyma at 4 h post-i.c.v.
injection of LPS. Thereafter, C3 levels in the brain par-
enchyma progressively increased from 4 to 24 h, peaking
at 24 h after LPS injection (Fig. 4a). The plasma levels of
C3 remained stable in the first 12 h and thereafter in-
creased progressively from 12 to 24 h after LPS treat-
ment (Fig. 4a). Notably, the C3 levels in the circulation
were significantly higher than those in the CNS, even
after a 100-fold dilution of the plasma sample (Fig. 4a).
We examined leukocyte recruitment in mice at 4 h
after receiving i.c.v. injection of LPS when C3 levels were
depleted from the circulation by using CVF. CVF treat-
ment depleted 95 % of the C3 in circulation after 4 h
(Fig. 4b). However, C3 levels in the brain at 4 h after the
CVF treatment were very low and not affected by CVF
(Fig. 4b). The plasma levels of C3a were increased sig-
nificantly at 4 h after LPS treatment. CVF treatment de-
pleted the majority of C3a in these LPS-treated animals
(Fig. 4c). C3 depletion from the circulation significantly
reduced rolling and adhesion (Fig. 4d) of leukocytes in
brain vessels. Furthermore, CVF treatment significantly
reduced the levels of LPS-stimulated P-selectin and E-
selectin (Fig. 4e) mRNA expression in the brain. Addition-
ally, CVF treatment reduced the protein levels of VCAM-1
significantly, and also reduced E-selectin slightly in LPS-
treated mouse brains (Fig. 4f).
C3a and C3aR participate in leukocyte recruitment into
the cerebral microvessels
C3a, the cleavage product of C3, is an anaphylatoxin that
triggers an inflammatory response engaging many types of
cells to release cytokines and other inflammatory media-
tors. Upon i.c.v. LPS administration, the levels of C3a in
the plasma were gradually increased at 4 h and substan-
tially further increased at 12 and 24 h (Fig. 5a). In contrast,
the C3a level in the brain parenchyma remained only
marginally increased during this period (Fig. 5a). C3a
acts on the receptor C3aR to exert its biological func-
tions [37, 38]. Using intravital microscopy, we further
observed that LPS i.c.v. injection caused very limited
rolling and adhesive (Fig. 5b) leukocytes in cerebral vas-
culature of C3aR−/− mice compared to the WT BALB/c
mice. Intravital microscopy revealed similar levels of
leukocyte-endothelial interactions in LPS-treated C5aR−/−
mice, as compared to LPS-treated WT C57BL/6J mice
(Fig. 5c). These results further confirmed that C3a and
C3aR, but not C5a or C5aR, is essential for endothelial
(See figure on previous page.)
Fig. 4 Effects of complement depletion on leukocyte recruitment into the brain parenchyma after i.c.v. LPS injection. a WT C57BL/6J mice were
treated i.c.v. with LPS, and C3 levels in the brain (without dilution, cleared from blood proteins) and plasma (diluted in 1:100) were determined by
Western blotting. b WT C57BL/6J mice received i.p. injections of CVF (10 μg/mouse) or PBS. After 4 h, WT C57BL/6J mice (n = 4) received i.c.v. LPS
injection, and after 4 h, plasma and brain samples were then collected for C3 Western blotting analysis. At 4 h after CVF injection, WT C57BL/6J
mice (n = 4) received i.c.v. LPS injection, and plasma samples were collected for C3a ELISA assay (c). At 4 h after i.p. injection of CVF to deplete
complement from the blood circulation, mice received i.c.v. LPS injection. Then, after 4 h, rolling and adhesion leukocytes were quantified using
intravital microscopy (d). e P-selectin and E-selectin mRNA expressions were measured using real-time PCR. f VCAM-1 and E-selectin protein levels
in the brain were examined by Western blotting (n = 4). Images are representative of four experiments. The ratio of VCAM-1 and E-selectin to β-actin
was determined through densitometry. The results are shown as the means ± SEM. *P < 0.05, **P < 0.01; n≥ 4 for all groups
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activation and subsequent leukocyte-endothelial interac-
tions in the brain inflammation.
C3 was essential for TNF-α-induced cerebral endothelial-
leukocyte interactions in vivo
To determine whether the reduced leukocyte recruitment
observed in C3−/− mice was indicative of defective inflam-
matory cytokine production, we measured the levels of
the inflammatory cytokines TNF-α and IL-1β in the brain
of the mice i.c.v.-treated with LPS. Interestingly, the TNF-
α levels in the brain were comparable in WT and C3−/−
mice (Fig. 6a, P > 0.05), whereas the IL-1β levels were sig-
nificantly reduced only after 24 h in C3−/− mice (Fig. 6b).
High levels of inflammatory cytokines (Fig. 6a, b) and
chemokines (data not shown) were detected in the brain,
while cerebral endothelial cells were not fully activated
in the absence of C3. Furthermore, we administered
i.c.v. injections of TNF-α into C3−/− mice and observed
that leukocyte rolling and adhesion were significantly re-
duced compared with WT mice (Fig. 6c, d). This result
Fig. 5 The C3a receptor is essential for LPS-induced leukocyte recruitment into the brain vasculature. a WT C57BL/6J mice were i.c.v.-treated with
LPS, and C3a levels in brain and plasma were then measured at 0, 4, 12, and 24 h after LPS injection by ELISA. WT BALB/c mice, C3aR−/− mice, WT
C57BL/6J mice, and C5aR−/− mice were i.c.v.-treated with LPS, and 4 h later, intravital microscopy was performed. Leukocyte rolling flux and adhesion
(b–c) are shown as the means ± SEM. **P < 0.01; n≥ 4 for all groups
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suggests that there may be a synergistic effect of C3 with
TNF-α on brain endothelial cell activation in vivo.
C3a induces brain endothelial cell activation and
adhesion molecule expression
To further confirm the role of C3a in cerebral endothe-
lial activation, primary brain endothelial cells were iso-
lated from WT C57/BL6J mice and treated with C3a
(200 ng/ml) and TNF-α (1 ng/ml) for 4 h. As expected,
TNF-α stimulated the increased ICAM-1 and VCAM-1
expression in brain endothelial cells from WT mice. C3a
induced ICAM-1 and VCAM-1 expression in brain
endothelial cells from WT mice but not C3aR−/− mice
(Fig. 7a). Further, C3a (200 ng/ml) and TNF-α (1 ng/ml)
have a synergistic effect on inducing the expression of
ICAM-1 and VCAM-1 in primary cerebral endothelial
cells (Fig. 7a). In addition, C3a induced the phosphoryl-
ation of p38 mitogen-activated protein kinase (MAPK)
and NF-κB in brain endothelial cells from the WT mice
(Fig. 7b). Therefore, C3a stimulates the expression of ad-
hesion molecules in primary cerebral endothelial cells in
vitro.
Discussion
The brain has long been considered to be an immune-
privileged organ. However, it is well appreciated that the
brain can respond to pathogens and danger signals; in
particular, resident glial cells generate inflammatory
cytokines and chemokines [39, 40], which in turn acti-
vate endothelial cells to recruit immune cells into the
brain [15]. In CNS inflammation, elevated levels of C3 in
CSF in humans and mice with bacterial meningitis have
been previously reported [41, 42]. In addition, several
studies have shown critical roles for complement com-
ponents in brain inflammation and reduced leukocyte
recruitment in complement-deficient animals [43, 44].
However, the detailed mechanism underlying the role of
the complement system in immune-cell recruitment into
the brain remains unknown. In the present study, we used
complement-deficient mice to evaluate the contributions
of the complement component C3 in leukocyte recruit-
ment into the brain during inflammation. Our results dem-
onstrated that C3 plays an essential role in cerebral
endothelial activation and contributes to neutrophil re-
cruitment into the brain parenchyma.
Complement activation occurs via three different path-
ways: classical, alternative, and the mannose-binding lectin
(MBL) pathways. As the most abundant component of the
complement system, C3 is indispensable for all three path-
ways of complement activation [45]. The cleavage and
activation of C3 initiate the membrane attack pathway,
through the formation of the membrane attack complex
(MAC), consisting of C5b, C6, C7, C8, and polymeric C9.
Neutrophil infiltration into the brain after i.c.v. LPS injec-
tion was compromised in C3−/− mice but not in C6−/−
mice, suggesting that reduced neutrophil recruitment is
Fig. 6 TNF-α has a synergistic effect with C3 on the induction of leukocyte recruitment in vivo. C3−/− mice and WT C57BL/6J mice were treated
i.c.v. with LPS, and TNF-α (a) and IL-1β (b) concentrations in the brain extracts were then measured using ELISA. WT C57BL/6J mice and C3−/−
mice were treated i.c.v. with TNF-α (0.2 μg), and intravital microscopy was performed to examine leukocyte recruitment in WT C57BL/6J mice and
C3−/− mice at 4 h after i.c.v. TNF-α injection. The data for leukocyte rolling flux (c) and adhesion (d) are shown as the means ± SEM. *P < 0.05,
**P < 0.01; n ≥ 4 for all groups
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not dependent on C6 or MAC assembly. The activation of
complement system has broad potential biological conse-
quences, because C3a functions as a chemotactic factor
for many types of immune cells [46]. Additionally, we ob-
served significant increased expression of KC(CXCL1) and
MIP-2(CXCL2) in the brains of C3−/− mice (data not
shown), and this expression likely provides sufficient
chemotactic strength for recruiting neutrophils into the
brain parenchyma. Therefore, a lack of chemotactic trac-
tion does not explain the inhibition of neutrophil recruit-
ment into the CNS in C3−/− mice.
Microglial involvement and endothelial activation are
two key steps in recruiting neutrophils into the CNS
during LPS-induced inflammation. Microglia are the
dominant sentinel cells for the detection of bacterial
products, and these cells release TNF-α, which activates
the endothelium and facilitates leukocyte rolling, adher-
ence, and recruitment into the CNS parenchyma [47]. In
previous studies, we showed that activated glial cells
control neutrophil recruitment by secreting TNF-α and
CXCL1 [15, 16]. It has recently been reported that C3 is
involved in microglial activation and priming under vari-
ous CNS inflammatory conditions [48]. Additionally,
complement C1q and C3 are critical for the innate im-
mune response to Streptococcus pneumoniae in the
CNS, and C3−/− mice were shown to display reduced ex-
pression of IL-1β, IL-12 and MIP-1γ in the CNS in a
meningitis animal model [28]. In the present study, only
a reduction in the IL-1β level at 24 h was detected in
the brain, which is consistent with the findings of previ-
ous studies. The levels of KC and MIP-2, essential
neutrophil-attracting chemokines, were higher in C3−/−
mice than WT mice at 24 h post-LPS injection (data not
shown). In contrast, TNF-α, a key cytokine for the stimu-
lation of endothelial activation and subsequent leukocyte
recruitment, did not decrease significantly in C3−/− ani-
mals. Taken together, these results indicate that C3 defi-
ciency did not affect glial cell activation. Upon LPS
stimulation, inflammatory cytokines and chemokines were
highly produced in these complement-deficient mice, indi-
cating that reduced recruitment might not reflect the
compromised glial activation.
Fig. 7 C3a stimulates primary brain endothelial activation and signaling pathways in vitro. Primary brain microvascular endothelial cells of WT
C57BL/6J mice and C3aR−/− mice (a) were stimulated with either vehicle, C3a (200 ng/ml), TNF-α (1 ng/ml), or C3a (200 ng/ml) plus TNF-α (1 ng/
ml) for 4 h, and the cell lysates were then analyzed for the expression of adhesion molecules using Western blotting. b Primary brain endothelial
cells from wild-type mice were incubated with either vehicle or C3a for the indicated time points, and phosphorylated forms of p65 NF-κB and
the MAPK p38 in cell lysates were then detected using Western blotting. Images are representative of four experiments
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The importance of endothelial cell activation in leukocyte
recruitment has been well documented [49, 50]. In a previ-
ous study, we reported that a significant increase in TNF-α
released from microglia avidly activates the endothelium,
causing an increase in adhesion molecule expression and
leukocyte recruitment [15]. Upon LPS injection, the glial
cells in C3−/− mice produced high levels of TNF-α in the
brain parenchyma, although significant reduction in
leukocyte rolling and adhesion was observed in the brain
microvasculature. Accordingly, the expression levels of ad-
hesion molecules (P-selectin, E-selectin, and VCAM-1),
which facilitate leukocyte rolling and adherence in brain
postcapillary venules, were downregulated in these mice.
Clearly, C3 deficiency affected endothelial activation and
significantly reduced E-selectin and VCAM-1 expression in
C3−/− animals, even in the presence of high levels of TNF-
α, indicating that C3 has synergistic effects with TNF-α on
endothelial activation in vivo. C3a stimulates cerebral endo-
thelial activation through its G protein-coupled receptor
C3aR. However, TNF-α was able to directly activate endo-
thelial cells to express adhesion molecules in the absence of
C3. The mechanism for this discrepancy between the in
vivo and in vitro observations remains to be elucidated.
The liver is a primary source of complement compo-
nents [51], most of which remain within the circulation.
Additionally, it has been reported that the local synthesis
of complement components in resident cells in the CNS
plays an essential role during CNS inflammation [52, 53].
The complement components detected in the CNS are
primarily derived from two sources: (1) complement com-
ponents are locally synthesized from different types of
neural glial cells in the brain [54, 55]; and (2) the BBB is
not impermeable, and complement components can by-
pass the barriers and penetrate into the brain parenchyma
within 12 h after BBB integrity has been compromised. C3
was only detected in the CNS 12 h after LPS injection.
Thus, considering that endothelial cell activation and
leukocyte rolling and adhesion were activated at 4 h post-
injection, when the C3 level in the brain homogenate was
nearly undetectable, C3 from the brain parenchyma was
unlikely to facilitate endothelial activation and leukocyte-
endothelial interactions. We propose that complement
components from the circulation may play a major role in
endothelial activation for the following two reasons. First,
endothelial activation was dependent on the expression of
adhesion molecules on the CNS endothelium. Notably,
most of the adhesion molecules were expressed on the lu-
minal side of the CNS endothelium. Thus, it would be eas-
ier for C3 in the circulation, rather than factors secreted
from the CNS, to mediate the expression of adhesion mol-
ecules on the luminal side of the brain endothelium.
Second, C3 levels in the circulation were much higher
than those in the brain, even after a 100-fold dilution of
the plasma samples. Additionally, CVF depletes the
complements in the circulation via C3 activation and
cleavage. This could potentially cause a massive increase
in C3a levels. However, the increase of C3a might not last
for a long period and might be depleted from circulation
in a very short time. We have already measured levels of
C3a at 4 h (the time point for endothelial activation) and
8 h after CVF injection and detected minimum amount of
C3a in the circulation. Further, CVF treatment significantly
reduced brain endothelial activation. Taken together, these
results indicate that it is the C3 in the circulation that facili-
tates brain endothelial activation.
Conclusions
Our results showed impaired neutrophil recruitment to
the brain vasculature in C3−/− mice and C3aR−/− mice.
Endothelial cell activation in these mice was affected by
C3 deficiency. Our present study also reveals that the
complement component C3a plays a critical role in brain
endothelial activation and the expression of adhesion
molecules, such as E-selectin and VCAM-1, in response
to local LPS administration. Moreover, we provide the
first evidence of a synergistic effect between C3 and
TNF-α for the activation of brain endothelial cells in
vivo. Our findings suggest that blocking or preventing
complement activation is a promising approach for sup-
pressing leukocyte recruitment and endothelial activa-
tion in inflammatory diseases in the brain.
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